Elias, A D <br/><br/>
Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  May 1997 
 - 147-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(97)00658-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antidotes--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cisplatin--therapeutic use<br/>Disease Progression<br/>Female<br/>Humans<br/>Leucovorin--therapeutic use<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging--classification<br/>Survival Rate<br/>Thoracotomy<br/>Thorax--radiation effects